|
Volumn 44, Issue 4, 2006, Pages 819-820
|
In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases? [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRANSFERASE;
IMMUNOSUPPRESSIVE AGENT;
AUTOIMMUNE HEPATITIS;
COHORT ANALYSIS;
FOLLOW UP;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LIVER BIOPSY;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER GRAFT;
LIVER NECROSIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RECURRENCE RISK;
REMISSION;
TREATMENT OUTCOME;
ALANINE TRANSAMINASE;
DISEASE PROGRESSION;
DISEASE SUSCEPTIBILITY;
HEPATITIS, AUTOIMMUNE;
HLA-DR ANTIGENS;
HUMANS;
LIVER CIRRHOSIS;
PROGNOSIS;
REMISSION, SPONTANEOUS;
TRANSAMINASES;
|
EID: 33644908839
PISSN: 01688278
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jhep.2005.11.050 Document Type: Letter |
Times cited : (11)
|
References (6)
|